Brokers Set Expectations for Foghorn Therapeutics Inc.’s Q1 2025 Earnings (NASDAQ:FHTX)
Foghorn Therapeutics Inc. (NASDAQ:FHTX – Free Report) – Wedbush issued their Q1 2025 earnings estimates for Foghorn Therapeutics in a note issued to investors on Monday, May 6th. Wedbush analyst R. Driscoll anticipates that the company will post earnings of ($0.36) per share for the quarter. Wedbush has a “Outperform” rating and a $13.00 price […]
More Stories
iShares iBonds Oct 2031 Term TIPS ETF (NYSEARCA:IBIH) Stock Price Up 0.1% – Time to Buy?
iShares iBonds Oct 2031 Term TIPS ETF (NYSEARCA:IBIH – Get Free Report) shares shot up 0.1% during trading on Tuesday...
Mobilicom (NASDAQ:MOB) Shares Up 8% – Should You Buy?
Mobilicom Limited (NASDAQ:MOB – Get Free Report) was up 8% during mid-day trading on Tuesday . The company traded as...
Jammin Java (OTCMKTS:JAMN) Shares Pass Above 200 Day Moving Average – Should You Sell?
Shares of Jammin Java Corp. (OTCMKTS:JAMN – Get Free Report) passed above its two hundred day moving average during trading...
Tesco (LON:TSCO) Share Price Passes Above 200 Day Moving Average – Here’s What Happened
Tesco PLC (LON:TSCO – Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The...
Capital Bancorp (NASDAQ:CBNK) Stock Crosses Above 200-Day Moving Average – Time to Sell?
Shares of Capital Bancorp, Inc. (NASDAQ:CBNK – Get Free Report) passed above its 200-day moving average during trading on Tuesday...
Gelteq (NASDAQ:GELS) Stock Price Up 0.4% – Still a Buy?
Gelteq Limited (NASDAQ:GELS – Get Free Report) shares shot up 0.4% during trading on Tuesday . The stock traded as...